Literature DB >> 19175403

Transplantation of human embryonic stem cell-derived neural precursor cells and enriched environment after cortical stroke in rats: cell survival and functional recovery.

Anna U Hicks1, Riikka S Lappalainen, Susanna Narkilahti, Riitta Suuronen, Dale Corbett, Juhani Sivenius, Outi Hovatta, Jukka Jolkkonen.   

Abstract

Cortical stem cell transplantation may help replace lost brain cells after stroke and improve the functional outcome. In this study, we transplanted human embryonic stem cell (hESC)-derived neural precursor cells (hNPCs) or vehicle into the cortex of rats after permanent distal middle cerebral artery occlusion (dMCAO) or sham-operation, and followed functional recovery in the cylinder and staircase tests. The hNPCs were examined prior to transplantation, and they expressed neuroectodermal markers but not markers for undifferentiated hESCs or non-neural cells. The rats were housed in either enriched environment or standard cages to examine the effects of additive rehabilitative therapy. In the behavioral tests dMCAO groups showed significant impairments compared with sham group before transplantation. Vehicle groups remained significantly impaired in the cylinder test 1 and 2 months after vehicle injection, whereas hNPC transplanted groups did not differ from the sham group. Rehabilitation or hNPC transplantation had no effect on reaching ability measured in the staircase test, and no differences were found in the cortical infarct volumes. After 2 months we measured cell survival and differentiation in vivo using stereology and confocal microscopy. Housing had no effect on cell survival or differentiation. The majority of the transplanted hNPCs were positive for the neural precursor marker nestin. A portion of transplanted cells expressed neuronal markers 2 months after transplantation, whereas only a few cells co-localized with astroglial or oligodendrocyte markers. In conclusion, hESC-derived neural precursor transplants provided some improvement in sensorimotor function after dMCAO, but did not restore more complicated sensorimotor functions.

Entities:  

Mesh:

Year:  2009        PMID: 19175403     DOI: 10.1111/j.1460-9568.2008.06599.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  99 in total

Review 1.  Current Neurogenic and Neuroprotective Strategies to Prevent and Treat Neurodegenerative and Neuropsychiatric Disorders.

Authors:  I M Carvalho; P B Coelho; P C Costa; C S Marques; R S Oliveira; D C Ferreira
Journal:  Neuromolecular Med       Date:  2015-09-15       Impact factor: 3.843

2.  Injectable Hydrogels with In Situ Double Network Formation Enhance Retention of Transplanted Stem Cells.

Authors:  Lei Cai; Ruby E Dewi; Sarah C Heilshorn
Journal:  Adv Funct Mater       Date:  2015-03-04       Impact factor: 18.808

Review 3.  Concise Review: Human-Animal Neurological Chimeras: Humanized Animals or Human Cells in an Animal?

Authors:  Andrew T Crane; Joseph P Voth; Francis X Shen; Walter C Low
Journal:  Stem Cells       Date:  2019-01-28       Impact factor: 6.277

Review 4.  Stem cell therapy for neurological disorders: A focus on aging.

Authors:  Hung Nguyen; Sydney Zarriello; Alexandreya Coats; Cannon Nelson; Chase Kingsbury; Anna Gorsky; Mira Rajani; Elliot G Neal; Cesar V Borlongan
Journal:  Neurobiol Dis       Date:  2018-09-13       Impact factor: 5.996

Review 5.  Experimental approaches to study functional recovery following cerebral ischemia.

Authors:  Anu Lipsanen; Jukka Jolkkonen
Journal:  Cell Mol Life Sci       Date:  2011-05-29       Impact factor: 9.261

6.  Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient?

Authors:  Aileen J Anderson; Daniel L Haus; Mitra J Hooshmand; Harvey Perez; Christopher J Sontag; Brian J Cummings
Journal:  Regen Med       Date:  2011-05       Impact factor: 3.806

Review 7.  Stem and progenitor cells for neurological repair: minor issues, major hurdles, and exciting opportunities for paracrine-based therapeutics.

Authors:  Issei S Shimada; Jeffrey L Spees
Journal:  J Cell Biochem       Date:  2011-02       Impact factor: 4.429

8.  Engineered Axonal Tracts as "Living Electrodes" for Synaptic-Based Modulation of Neural Circuitry.

Authors:  Mijail D Serruya; James P Harris; Dayo O Adewole; Laura A Struzyna; Justin C Burrell; Ashley Nemes; Dmitriy Petrov; Reuben H Kraft; H Isaac Chen; John A Wolf; D Kacy Cullen
Journal:  Adv Funct Mater       Date:  2017-09-04       Impact factor: 18.808

Review 9.  Important precautions when deriving patient-specific neural elements from pluripotent cells.

Authors:  Xuejun H Parsons; Yang D Teng; Evan Y Snyder
Journal:  Cytotherapy       Date:  2009       Impact factor: 5.414

10.  A defined and xeno-free culture method enabling the establishment of clinical-grade human embryonic, induced pluripotent and adipose stem cells.

Authors:  Kristiina Rajala; Bettina Lindroos; Samer M Hussein; Riikka S Lappalainen; Mari Pekkanen-Mattila; Jose Inzunza; Björn Rozell; Susanna Miettinen; Susanna Narkilahti; Erja Kerkelä; Katriina Aalto-Setälä; Timo Otonkoski; Riitta Suuronen; Outi Hovatta; Heli Skottman
Journal:  PLoS One       Date:  2010-04-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.